Cargando…

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade

Targeted radionuclide therapy plays an increasingly important role in managing endocrine-related tumors and significantly advances the therapeutic landscape for patients with these diseases. With increasing FDA-approved therapies and advances in the field, come an increased knowledge of the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Toubah, Taymeyah, Strosberg, Jonathan, Hallanger-Johnson, Julie, El-Haddad, Ghassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694449/ http://dx.doi.org/10.3389/fendo.2023.1187870

Ejemplares similares

What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020)

Chemotherapy in Neuroendocrine Tumors
por: Das, Satya, et al.
Publicado: (2021)

Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
por: Al-Toubah, Taymeyah, et al.
Publicado: (2022)

Letter to the Editor From Hallanger Johnson and El-Haddad: “Yttrium-90 Selective Internal Radiation Therapy Plus Cryoablation for Recurrent Adrenocortical Carcinoma With Liver Metastases”
por: Hallanger Johnson, Julie, et al.
Publicado: (2022)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
por: Lu, Sen, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Editorial: Advances in the Endocrine Role of the Skeleton
por: Baldelli, Roberto, et al.
Publicado: (2020)

FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
por: Idrees, Zarwa, et al.
Publicado: (2022)

Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy
por: Keerty, Dinesh, et al.
Publicado: (2020)

Editorial: Bone: Endocrine Target and Organ
por: Brunetti, Giacomina, et al.
Publicado: (2017)

Editorial: Further advances in understanding the endocrine cancer microenvironment
por: Coperchini, Francesca, et al.
Publicado: (2022)

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
por: Al-Toubah, T., et al.
Publicado: (2021)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Clinical Advances and Perspectives in Targeted Radionuclide Therapy
por: Lepareur, Nicolas, et al.
Publicado: (2023)

Editorial: Endocrine-related cardiovascular diseases: Recent advances in diagnosis and treatment
por: Bhat, Audesh, et al.
Publicado: (2023)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation
por: Eng, Cathy, et al.
Publicado: (2021)

Editorial: Cell Signaling in Tumors of Endocrine and Endocrine-Responsive Tissues
por: Perks, Claire, et al.
Publicado: (2019)

Therapeutic advances in sickle cell disease in the last decade
por: Shet, Arun S., et al.
Publicado: (2017)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

Editorial: Recent advances in vitamin D supplementation for improved reproductive endocrine and metabolic parameters
por: Alam, Faiza, et al.
Publicado: (2023)

Acupuncture as multi-targeted therapy for the multifactorial disease obesity: a complex neuro-endocrine-immune interplay
por: Landgraaf, Raymond Guy, et al.
Publicado: (2023)

Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011)

Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2022)

Editorial: Advances of endocrine and metabolic cardiovascular outcomes: From basic to clinical science, volume II
por: Cheng, Wenzhuo, et al.
Publicado: (2023)

Editorial: Endocrine and metabolic diseases – genetic impact and therapies
por: Jéru, Isabelle, et al.
Publicado: (2022)

Neural and Endocrinal Pathobiochemistry of Vitiligo: Comparative Study for a Hypothesized Mechanism
por: Kotb El-Sayed, Mohamed-I., et al.
Publicado: (2018)

Editorial: Endocrine Modulators of Neurological Processes: Potential Treatment Targets of Pediatric Neurological Diseases
por: Ni, Hong, et al.
Publicado: (2021)

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
por: Vijayvergia, Namrata, et al.
Publicado: (2020)

Advancement of orthodontic and craniofacial research sites in the last three decades
por: Anbuselvan, Gobichettipalayam Jagatheeswaran, et al.
Publicado: (2012)

Advances in Type 1 Diabetes Technology Over the Last Decade
por: Zimmerman, Chelsea, et al.
Publicado: (2019)

Pediatric acute kidney injury: new advances in the last decade
por: Sethi, Sidharth K., et al.
Publicado: (2021)

Editorial: Endocrine Frailty in the Elderly
por: Aversa, Antonio, et al.
Publicado: (2019)

Editorial: Endocrine Disrupters and Metabolism
por: Gibert, Yann, et al.
Publicado: (2019)

Endocrine Regulation on Bone by Thyroid
por: Zhu, Siyuan, et al.
Publicado: (2022)

Editorial: Epilepsy and endocrine function
por: Miziak, Barbara, et al.
Publicado: (2023)

Copeptin analysis in endocrine disorders
por: Moodley, Nareshni
Publicado: (2023)

Editorial: Prediabetes and endocrine function
por: Khathi, Andile, et al.
Publicado: (2023)

Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system
por: Giagulli, VA, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32hn9blboi2m8ekri0l1oh25g7